Arbutus Biopharma, X-Chem and Proteros biostructures Achieve First Milestone Under COVID-19 Discovery Research and License Agreement Read more
CP-COV03, a niclosamide-based oral antiviral drug, under study as possible cure for COVID-19 variants Read more
Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company Read more
Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities Read more
FDA Approves Merck’s KEYTRUDA (pembrolizumab) as Adjuvant Treatment for Adult and Pediatric (≥12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection Read more